These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2714007

  • 1. Retention of antimony in hair during leishmaniasis treatment.
    Dorea JG, Merchan-Hamann E, Ryan DE, Holzbecher J.
    Clin Chim Acta; 1989 Feb 22; 179(3):341-5. PubMed ID: 2714007
    [No Abstract] [Full Text] [Related]

  • 2. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
    Costa JM, Marsden PD.
    Rev Soc Bras Med Trop; 1988 Feb 22; 21(2):85-6. PubMed ID: 3249826
    [No Abstract] [Full Text] [Related]

  • 3. Antimony accumulation in hair during treatment of leishmaniasis.
    Dorea JG, Costa JM, Holzbecher J, Ryan DE, Marsden PD.
    Clin Chem; 1987 Nov 22; 33(11):2081-2. PubMed ID: 3677383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intralesional glucantime in Leishmania braziliensis braziliensis infections.
    Barrios LA, Costa JM, Netto EM, Vexenat CO, Cuba CC, Marsden PD.
    Trans R Soc Trop Med Hyg; 1986 Nov 22; 80(1):173-4. PubMed ID: 3726989
    [No Abstract] [Full Text] [Related]

  • 6. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J, Alvar J, Polo RM, González-Lahoz JM.
    Am J Med; 1988 Jul 22; 85(1):128. PubMed ID: 3389377
    [No Abstract] [Full Text] [Related]

  • 7. Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta).
    Grimaldi G, Porrozzi R, Friedrich K, Teva A, Marchevsky RS, Vieira F, Miekeley N, Paumgartten FJ.
    Antimicrob Agents Chemother; 2010 Jan 22; 54(1):502-5. PubMed ID: 19822700
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
    Sampaio RN, Marchán EM, Vexenat A, Tristão RJ, Marsden PD.
    Mem Inst Oswaldo Cruz; 1990 Jan 22; 85(3):373-4. PubMed ID: 2134714
    [No Abstract] [Full Text] [Related]

  • 12. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G, Jama H, Ozsoylu S.
    Trans R Soc Trop Med Hyg; 1988 Jan 22; 82(3):417. PubMed ID: 3232176
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
    Netto EM, Marsden PD, Llanos-Cuentas EA, Costa JM, Cuba CC, Barreto AC, Badaró R, Johnson WD, Jones TC.
    Trans R Soc Trop Med Hyg; 1990 Jan 22; 84(3):367-70. PubMed ID: 2260171
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T, Lehn N, Landthaler M, Stolz W.
    Dermatology; 2003 Jan 22; 206(3):269-72. PubMed ID: 12673089
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.